Your browser doesn't support javascript.
loading
Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line therapy: results from the IMPACT RCC claims data analysis.
Hutson, Thomas E; Liu, Frank X; Dieyi, Christopher; Kim, Ruth; Krulewicz, Stan; Kasturi, Vijay; Bhanegaonkar, Abhijeet.
Affiliation
  • Hutson TE; Texas Oncology Sammons Cancer Center, Dallas, TX.
  • Liu FX; EMD Serono Inc., Rockland, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
  • Dieyi C; STATinMED Research, Plano, TX.
  • Kim R; Pfizer Inc., New York, NY.
  • Krulewicz S; Pfizer Inc., Collegeville, PA.
  • Kasturi V; EMD Serono Inc., Rockland, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
  • Bhanegaonkar A; EMD Serono Inc., Rockland, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
J Manag Care Spec Pharm ; 27(9): 1171-1181, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34165322
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Disease Progression / Protein Kinase Inhibitors / Neoplasm Metastasis Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Manag Care Spec Pharm Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Disease Progression / Protein Kinase Inhibitors / Neoplasm Metastasis Type of study: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Manag Care Spec Pharm Year: 2021 Document type: Article Country of publication: